NCT06772896View on ClinicalTrials.gov

Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis

NACompletedINTERVENTIONAL

Enrollment

851

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

April 17, 2025

Study Completion Date

April 17, 2025

Conditions

SclerodermaSystemic Sclerosis (SSc)Scleroderma (Limited and Diffuse)

Interventions

OTHER

Reordered PHQ-8

Participants will be administered the PHQ-8 somatic items separately from the psychological items, outside the context of a depression questionnaire.

Trial Locations (2)

H3T 1E2

Jewish General Hospital, Montreal

Lady Davis Institute for Medical Research, Montreal

All Listed Sponsors

lead

Lady Davis Institute

OTHER

NCT06772896 - Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis | Biotech Hunter | Biotech Hunter